The discovery dovetails with a multi‑year surge in funding for gene‑editing, CRISPR‑based therapies, and digital‑health platforms that are increasingly exploring blockchain for secure data sharing. As capital chases the next wave of breakthrough therapeutics, we expect a spill‑over into health‑tech crypto projects and biotech equities, reinforcing the broader theme of “science‑driven” capital flows that have been reshaping risk‑on allocations since 2024.

Nature published a research article highlighting the role of X‑chromosome genes in health and disease susceptibility.